Karman Holdings, Inc.(KRMN) · Aerospace & Defense

Karman Holdings: A Long-Term Owner's Perspective

Other languages
Quick ReadPlain-language overview · read this first

Karman Holdings is a 2025 IPO defense and aerospace critical systems supplier. It provides mission-critical payload protection, aerodynamic interstages, and propulsion systems for U.S. missile defense, hypersonic, tactical missile, and commercial/government space launch programs. Its edge comes from engineering integration across design, testing, certification, and volume production, not from generic components.Rating Watch——an attractive arena with deep customer embedding, but at the current price this is not an entry point for conservative long-term value investors. It is the early shape of a good company at a bad price.

The tension sits in cash flow and valuation. Revenue is surging, with 2023–2025 compound growth of about 29.6% and first-quarter year-over-year growth of 51%, but growth is consuming working capital: operating cash flow turned negative in 2025, free cash flow was about -42.46 million dollars, net debt/EBITDA was about 5.4 times, and goodwill plus intangible assets have already pushed tangible net worth below zero. A market cap of about 6.87 billion dollars implies about 229 times conservative Owner Earnings, so there is clearly no margin of safety.

The report cross-checks intrinsic value using three methods: discounted Owner Earnings, relative valuation, and asset-based valuation. It gives conservative, reasonable, and optimistic intrinsic value ranges of 7–12, 13–20, and 25–33 dollars per share. Even against the optimistic range, the current price of 51.84 dollars still carries a premium of more than 50%. The ideal buying range is 9–14 dollars; the current price is plainly in overvalued territory. The worst-case scenario is not slower growth, but continued growth paired with poor shareholder returns, potentially causing a 60%–80% permanent loss.

Lead

Karman Holdings sits in high-quality defense and space niches with deep customer embedding, but its current financial profile is still uneven. The core thesis is that this may become a good mission-critical aerospace and defense platform, yet 2025 operating cash flow turned negative, leverage is high, tangible book value is negative, and the current price of USD 51.84 is far above a reasonable intrinsic value range of USD 13-20. Research rating Watch: an emerging good business, but at a bad price.

Full report

Prices in the article are as of publication; see the valuation band above for the live price.

Bottom Line First

Investment rating: Watch. If we view Karman Holdings as a business to own for the long run, rather than as a stock to chase for short-term upside, my conclusion is this: the business itself is understandable and its endgame may not be poor, but at the current price it does not meet the buy-point standard for conservative long-term value investing. The company operates in attractive areas such as U.S. missile defense, tactical missiles, and commercial/government space. Its products are embedded in customers' critical systems, qualified supplier switching costs are high, and order visibility is improving. At the same time, it remains highly dependent on major customers, large programs, defense budgets, and continuing M&A. Real cash conversion is not yet strong, and the balance sheet became visibly heavier after Q1 2026. More importantly, the current market price already discounts a long period of high growth and smooth integration. It does not give you much room to be wrong.

My core judgment can be summarized in several points. This is an understandable business: it provides mission-critical systems and subsystems for missiles, interceptors, air defense, space launch, and related programs, with the core capability lying in the integration of front-end design, testing, qualification, and volume production. It may be a decent business, though not one so exceptional that price can be ignored: the end markets are attractive, customer switching is slow, and program lives are long, but cash flow requires working-capital support, while M&A and leverage are both rising. The company's moat is forming, but it has not yet been fully proven as wide and self-reinforcing. It looks more like a combination of engineering, qualification, process, and relationship barriers than a brand or network-effect moat. As for the margin of safety at the current price: there is none. Whether one looks at P/S, book multiples, EV/EBITDA, or a conservative owner-earnings discount model, the current price looks closer to "prepaying for the future" than to "leaving room for error." In terms of suitable investor type, it is closer to a growth or thematic investor willing to accept high-valuation risk in defense growth stocks and M&A integration uncertainty. It is not very suitable for conservative long-term value investors who emphasize current free cash flow and a margin of safety.

There are also three major uncertainties. First, whether high-growth orders can truly convert into high-quality cash flow, rather than continuing to accumulate in receivables, contract assets, and capacity investment. Second, after multiple acquisitions since 2025 and the Seemann/MSC acquisitions in 2026, whether debt, integration, and returns on capital can improve. Third, part of the currently disclosed high-demand signal still consists of contingent demand commitments, rather than signed firm contracts.

Business, Industry, and Moat

Karman focuses on "mission-critical" systems and subsystems in missile defense and space programs. Its core products can be grouped into three technical families: payload protection and deployment systems, aerodynamic interstage systems, and propulsion systems. It does not sell generic parts. It sells critical pieces after the integration of design, testing, qualification, and manufacturing, deployed in high-priority missile, air defense, interceptor, launch, and space programs. In 2025, the company said it supported 130+ active production and development programs, served 80+ customers, and had no single program representing more than 12% of average revenue in either 2025 or 2024. From a long-term owner's perspective, this is a business built on engineering manufacturing + qualification barriers + customer embedding. The logic is clear and relatively easy to understand.

On the revenue side, in 2025 the company was mainly distributed across three end markets: hypersonics and strategic missile defense, tactical missiles and integrated defense systems, and space and launch. By Q1 2026, after Seemann/MSC were consolidated, it also added exposure to maritime defense. The three major markets were broadly balanced in 2025, while Q1 2026 revenue grew year over year to USD 151.2 million, with Space & Launch, Tactical Missiles, and Hypersonics still serving as the main axes. This distribution helps reduce volatility from any single end market, but it does not mean revenue is "stable like a utility." Demand remains program-based, contract-based, and budget-based.

Customer quality is high, but concentration is not low. In 2025, three customers each accounted for 28.5%, 12.8%, and 10.2% of annual revenue. In Q1 2026, two customers accounted for 25.6% and 11.6% of revenue, respectively. There is also concentration on the supplier side: at the end of 2025, a single supplier represented about 23.8% of accounts payable. This means demand is not unpredictable, but it is not diversified. If you imagine yourself as the owner of the business, this is not a model that relies on mass fragmented customers renewing repeatedly. It is a model built on a small number of high-value large customers, long-cycle programs, and deeply embedded qualifications.

The industry itself is attractive, but with a policy-driven character. The U.S. FY2027 budget request continues to increase spending on missile defense, hypersonic defense, and related procurement. At the same time, the FAA's official forecast for commercial space from 2025 to 2034 also shows a long-term expansion trend in U.S. commercial launch and reentry activity. Karman is exposed to both "defense industrial restocking/capacity expansion" and "commercial space launch growth," so its end-market attractiveness is higher than that of general industrial manufacturing. My industry attractiveness score is 4/5.

On the moat, I prefer to define it as a combined barrier of engineering capability, program qualifications, process IP, materials and manufacturing know-how, and switching costs. The company discloses IP including Design IP, Proprietary IP, and Process IP. It also emphasizes that it holds sole-source or single-source positions in many programs. Once a supplier has completed qualification for a specific program and delivered reliably, customers generally do not restart a long and expensive requalification process lightly. In other words, its barrier is not "consumers cannot live without the brand." It is "the prime contractor has little reason to take the risk of redoing qualification and system integration." This type of barrier is real in the defense and space supply chain.

But I would not give it a full score. First, competition still exists, especially from component suppliers, vertically integrated rivals, and prime customers' own "make or buy" decisions. Second, the company's competitive improvement in recent years has a clear M&A puzzle-piece character. That means part of the integrated capability you see comes from capital deployment, not entirely from organic development within a single enterprise. Third, while the industry has tailwinds, it can also be affected by budgets, program pacing, and technology-path shifts. My moat-strength score is 3/5: real and effective, but not yet "very wide."

If the stock market closed for 5 years, I would be willing to continue studying and holding this enterprise from a purely "business" perspective. But if the question is whether I would lock it away for 5 years at today's price, I would not be comfortable. For a long-term owner, "would I be willing to own the business" and "would I be willing to buy the stock at today's price" are two different questions. The former leans positive. The latter leans negative.

Management and Capital Allocation

Management and capital allocation are the areas where Karman most needs a valuation discount. Current CEO Jon Rambeau took office in March 2026, while former CEO Tony Koblinski retired but remains on the board. Investors are now facing a combination of new CEO + old platform + continued frequent M&A. Management stability and the long-term track record are still being formed. For conservative investors, this is not fatal, but it does reduce analyzability.

Equity alignment is not weak, but it is far from the point where "management is so deeply in the same boat as you that mistakes are unaffordable." The 2026 proxy statement shows directors and executives collectively owning about 5.77% of shares. Former CEO Tony Koblinski held about 1.75%, director David Stinnett about 2.64%, while CFO Mike Willis and COO Jonathan Beaudoin each held less than 1%. This means alignment exists, but it is not as strong as in some founder- or family-controlled companies.

The capital allocation playbook is very clear: build the platform first, then keep acquiring capabilities. In 2025, the company completed three acquisitions, MTI, ISP, and Five Axis, with total net cash outflow for acquisitions of about USD 211.9 million. In Q1 2026, it acquired Seemann Composites and Materials Sciences for total consideration of about USD 232.8 million, mainly financed with new borrowings. The strategic logic is not messy: these acquisitions all reinforce high-temperature materials, propulsion, nozzles, composites, and maritime defense capabilities, and they are industrially consistent with the existing platform. The problem is not that "the direction is wrong." The problem is buying quickly, buying a lot, and whether those deals can truly convert into real per-share cash earnings after closing. So far, this has not been sufficiently proven.

On shareholder friendliness, two points need to be seen together. First, the July 2025 secondary offering was essentially a sale by existing shareholders, not corporate financing. The company did not receive new operating funds from that secondary offering. Second, at least based on public financial statements from 2023 to 2025, the company has not paid a stable dividend or carried out regular buybacks. Cash has been prioritized for acquisitions, capacity expansion, and debt arrangements. This is not necessarily bad for growth investors, but for value investors it means you are buying a "still heavily reinvesting platform story," not a mature cash cow already returning capital to shareholders.

Governance quality also has clear blemishes. In its 2025 10-K, the company acknowledged that as of December 31, 2025, it had material weaknesses in internal control, including insufficient maintenance of COSO components, insufficient IT general controls, and control deficiencies at significant business-process levels. This does not equal financial fraud, but for a newly public company that also depends on M&A integration and has a rapidly changing financial structure, it directly raises the discount rate you should require for financial-statement quality and capital-allocation effectiveness.

In addition, the former CEO received about USD 5.257 million in cash bonuses from Phantom Units after the IPO. This arrangement is not necessarily unreasonable, but it again reminds you that the company has carried a clear private-equity platform transformation imprint from the beginning. It is not a traditional "old high-quality public company" culture that has compounded for decades. Overall, I score management and capital allocation at 3/5, and this 3 is a cautious 3.

Financial Quality

Start with growth. Revenue in 2023, 2024, and 2025 was USD 280.7 million, USD 345.3 million, and USD 471.5 million, respectively, representing a two-year CAGR of about 29.6%. Q1 2026 revenue was USD 151.2 million, up about 51% from USD 100.1 million in the same period of 2025. On "surface growth," Karman looks very strong.

Now look at the earnings structure. Gross margin rose from 37.6% in 2023 to 38.3% and then 40.3% in 2025, suggesting improvement in product mix and pricing/execution quality. But operating margin did not move up in a similarly stable way. The 2025 operating margin was about 15.5%, below 18.4% in 2024. More importantly, net margin remains in the low single digits, at around 3.7% in both 2024 and 2025. In other words, revenue is growing rapidly, but the accounting profit ultimately accruing to shareholders has not shown the thick profit band commonly seen in high-quality compounders.

Cash flow is the most important dividing line. Operating cash flow was USD 20.33 million in 2023 and USD 26.65 million in 2024, but it turned to negative USD 22.12 million in 2025. Capital expenditures over the same period were USD 16.78 million, USD 15.25 million, and USD 20.34 million, so 2025 free cash flow was about negative USD 42.46 million. In Q1 2026, operating cash flow was only USD 0.209 million, while capital expenditures were USD 7.375 million, still showing no strong cash release. For a long-term owner, this is not a "small blemish." It is a red light that must be watched closely.

The cash-flow weakening did not appear from nowhere. The deterioration in 2025 operating cash flow was mainly dragged down by a USD 49.08 million increase in contract assets, a USD 18.36 million increase in receivables, and a USD 16.88 million decrease in payables and various accrued liabilities. By Q1 2026, contract assets, receivables, and inventory were still rising. From an owner mindset, this shows that the company's current growth is not "asset-light growth that automatically turns into cash." It is growth that consumes working capital. As long as this feature persists, rapid growth on the income statement cannot be equated directly with rapid growth in distributable cash flow.

Leverage is also clearly rising. Total debt was about USD 580.5 million at the end of 2025 and rose to USD 855.5 million by Q1 2026. Cash rose from USD 33.96 million to USD 73.80 million over the same period, but net debt still reached about USD 781.7 million. Based on full-year 2025 adjusted EBITDA of USD 145.3 million, net debt/EBITDA was about 5.4x. Even using the midpoint of the company's 2026 EBITDA guidance, about USD 214 million, net debt/EBITDA was still about 3.7x. For a small- to mid-cap defense supplier that has not yet proven long-term stable cash release, this is not a light debt load.

Interest coverage is not wide either. In 2025, operating profit was USD 72.94 million and net interest expense was USD 44.57 million, implying EBIT interest coverage of only about 1.6x. Even after adding back depreciation and amortization, EBITDA/interest is only in the low- to mid-single digits. A 10-year value investment that would truly let me sleep well usually should not place itself in such a narrow financial buffer zone.

Asset quality is an even clearer issue. At the end of 2025, the company carried USD 352.5 million of goodwill and USD 285.9 million of intangible assets on the balance sheet, totaling about USD 638.4 million. Shareholders' equity at the same time was only USD 382.7 million. This means the company's tangible net worth was already negative at year-end 2025. If you look for downside protection through an asset-based lens, Karman is not cheap. It is fragile.

The core financial metrics are summarized below:

Metric 2023 2024 2025 Q1 2026
Revenue (USD mn) 280.7 345.3 471.5 151.2
YoY growth 23.0% 36.6% 51.0%
Gross margin 37.6% 38.3% 40.3% More data needed
Operating margin 17.3% 18.4% 15.5% More data needed
Net margin 1.6% 3.7% 3.7% 5.2%
Operating cash flow (USD mn) 20.3 26.6 -22.1 0.2
Capital expenditures (USD mn) 16.8 15.3 20.3 7.4
Free cash flow (USD mn) 3.6 11.4 -42.5 -7.2
Cash (USD mn) 5.5 11.5 34.0 73.8
Total debt (USD mn) 402.2 441.0 580.5 855.5
Shareholders' equity (USD mn) 182.5 196.0 382.7 405.7

The figures in the table are based on the company's 2024 and 2025 10-K filings, the Q1 2026 10-Q, and simple ratio calculations made in this report. Because the Q1 report does not disclose a complete annualized profit-margin framework and the impact of acquisitions is significant, some quarterly margin/ROIC indicators are not mechanically extrapolated.

Overall, I believe Karman's accounting profit is not poor, but its cash profit is not solid. Growth requires continuing working-capital support and M&A. I have not seen direct evidence of financial fraud, but material internal-control weaknesses mean investors cannot be complacent about the quality of the numbers. In an economic downturn, program delay, or budget-disbursement fluctuation, the company may not immediately face distress, but the financial comfort level is certainly not high.

Owner Earnings

Under Buffett-style Owner Earnings thinking, EBITDA cannot be treated as distributable profit, and short-term net income cannot simply be treated as "money the owner can take out." A more reasonable starting point is: net income + non-cash expenses - maintenance capital expenditures - working capital required to maintain and grow the business.

Take 2025 as an example. Karman's net income was about USD 17.37 million. Adding back depreciation and amortization of USD 42.74 million and stock-based compensation of USD 1.41 million gives about USD 61.52 million of "rough operating cash earnings." But you cannot treat all of that USD 61.52 million as distributable funds, because capital expenditures from 2023 to 2025 remained in the USD 15 million to USD 20 million range, while working capital continued to be consumed by receivables and contract assets. In 2025, contract assets alone consumed USD 49.08 million of cash, and receivables consumed another USD 18.36 million.

Therefore, my conservative Owner Earnings estimate is: 2025 Owner Earnings were roughly USD 25 million to USD 35 million, with a midpoint of about USD 30 million. This estimate assumes maintenance capital expenditures of about USD 17 million and retains "part, but not all" of the unusually large 2025 working-capital outflow. That is because the trend in contract assets/receivables across 2023, 2024, 2025, and Q1 2026 shows that Karman's growth does keep absorbing cash. The 2025 cash-flow deterioration therefore cannot be simply explained away as entirely one-off. This Owner Earnings figure is not disclosed by the company; it is a conservative estimate based on public financial statements.

Using the USD 30 million midpoint, the current market capitalization of about USD 6.87 billion equals roughly 229x Owner Earnings. Even if you treat 2026 revenue and EBITDA guidance as credible and assume successful integration and clear cash-flow improvement, this multiple is hard to call "cheap." From an owner-earnings perspective, the current market value looks like it is prepaying all tuition for several future years of successful delivery at once.

Looking more strictly at disclosed free cash flow, 2025 free cash flow was negative USD 42.46 million. Using full-year 2025 plus Q1 2026 on a rolling basis, trailing 12-month free cash flow is still clearly negative. This shows that the company's true distributable cash flow, at least at the current stage, is long-term below, and at times materially below, net income. This is not an issue that value investors can easily ignore.

Intrinsic Value and Margin of Safety

Start with the current market snapshot. KRMN's latest share price is about USD 51.84, and its market capitalization is about USD 6.87 billion.

I do not believe a single valuation method can solve a stock like Karman, which combines "high growth + frequent M&A + cash flow that is not yet smooth." So I used three methods for cross-checking.

In the Owner Earnings discount method, I use three relatively cautious scenarios rather than extrapolating market sentiment into superlinear growth:

  • Bear case: starting from 2026 Owner Earnings of USD 40 million, with 10% annual growth for the next 10 years, a 10% discount rate, and 3% terminal growth. This corresponds to value per share of about USD 7-12.

  • Base case: starting from 2026 Owner Earnings of USD 55 million, with 15% annual growth for the next 10 years, a 10% discount rate, and 3% terminal growth. This corresponds to value per share of about USD 13-20.

  • Bull case: starting from 2026 Owner Earnings of USD 75 million, with 18% annual growth for the next 10 years, a 9% discount rate, and 3.5% terminal growth. This corresponds to value per share of about USD 25-33. These assumptions already embed successful order conversion, successful integration, and improvements in margins and cash conversion. In other words, even in the bull case, the current price is not cheap.

The relative valuation method shows that KRMN is not "a little expensive"; it is clearly expensive. Based on current market capitalization and 2025 revenue, KRMN's P/S is about 14.6x. Based on Q1 2026 shareholders' equity, P/B is about 16.9x. Based on 2025 adjusted EBITDA, EV/EBITDA is about 52.7x. Even using the midpoint of 2026 EBITDA guidance, EV/EBITDA is still about 35.8x. For comparison, Ducommun's current market capitalization and 2025 financials imply P/S of about 2.8x, P/B of about 3.5x, and EV/EBITDA of about 18.8x. Kratos, already a defense technology stock to which the market is willing to assign a high-growth premium, trades on 2025 financials at P/S of about 7.8x and P/B of about 5.3x. This shows that Karman is not "slightly more expensive than peers." It stands ahead of peers on valuation.

The asset/liquidation value method is even less friendly to KRMN. At the end of 2025, shareholders' equity was about USD 382.7 million, equal to book value per share of about USD 2.9-3.1. But because goodwill and intangible assets together totaled about USD 638.4 million, the company's tangible net assets were negative at that time. This means that if your investment logic requires "asset backing" for margin of safety, this stock does not qualify. Its value depends almost entirely on future earning power and customer relationships, not on book net assets.

Based on the three methods above, my ranges are as follows:

  • Bear-case intrinsic value range:USD 7-12/share.

  • Reasonable intrinsic value range:USD 13-20/share.

  • Bull-case intrinsic value range:USD 25-33/share.

  • At the current USD 51.84, the stock is roughly at a 159%-299% premium to the reasonable range. Even relative to the bull-case range, it still carries about a 57%-107% premium.

  • For conservative value investors, the required margin of safety should be at least 25%-30%, so my ideal buy-price range is roughly USD 9-14. If you allow optimistic assumptions into the model, relaxing this to USD 15-20 still only makes it "barely worth studying," not a comfortable buy point.

  • Acceptable holding-price range: roughly USD 15-25, provided subsequent cash-flow delivery improves materially.

  • Clearly overvalued price range: roughly above USD 35. The current price falls into this category.

Therefore, the margin-of-safety judgment is straightforward: there is none; it is not merely unclear, it is clearly absent. The two most fragile assumptions are: first, the company can convert backlog and contingent demand into cash quickly and with high quality; second, the market will still be willing to give it a high growth-stock valuation 10 years from now. If either fails, long-term returns from buying at the current price may be mediocre or even negative. This is a classic case of an emerging good company, but a bad price.

Risks, Comparisons, and Checklist

The most important risk is not short-term share-price volatility. It is permanent capital loss. For KRMN, I think the core risks are concentrated in the following categories.

First, competition and customer insourcing risk. Although the company emphasizes the scarcity of integrated systems suppliers, its core customers are large prime contractors. Whether customers make or outsource is always an active choice. At the same time, component and subsystem suppliers can also extend upward. Karman's barriers are effective, but they are not unchallengeable.

Second, order conversion and technology-path risk. In Q1 2026, the company raised full-year guidance and said period-end backlog exceeded USD 1 billion. In May 2026, it also disclosed contingent demand commitments from four major customers with total potential value exceeding USD 1 billion. But "high demand" does not equal "high-quality, billable, cash-collectible firm contracts." If primes' final orders, launch schedules, or budget approvals are delayed, Karman's advance capacity expansion and capital expenditures will occur before cash collections.

Third, financial leverage and M&A integration risk. Since 2025, the company has acquired frequently and debt has risen quickly. If acquisition synergies do not materialize or some new capacity ramps poorly, net debt/EBITDA will be harder to bring down. For a small- to mid-cap company, leverage is not an issue that can be ignored simply because the industry is attractive.

Fourth, customer concentration and supply-chain risk. In 2025, the top three customers contributed more than half of revenue, while a single supplier accounted for nearly one quarter of accounts payable. This amplifies the impact of any program delay, acceptance issue, or supply bottleneck.

Fifth, accounting and internal-control risk. I have not seen direct evidence of fraud, but the material internal-control weaknesses disclosed by the company are enough to require investors to demand a larger valuation discount, not a smaller one.

The strongest bear case can actually be compressed into one sentence: Karman is currently priced by the market more like a "perfectly executed defense compound-growth platform," but in reality it is still an industrial company with high customer concentration, M&A dependence, unproven cash flow, and rising leverage. If this judgment is correct, the worst case is not simply slower growth. It is "growth continues, but shareholder returns are poor," because more revenue may only bring more working-capital absorption, higher debt, and thinner real free cash flow.

What facts would make me admit I was wrong and raise the rating? I would watch five things: operating cash flow recovering for several consecutive periods and materially exceeding net income; net debt/EBITDA continuing to fall below 2.5x; material internal-control weaknesses being remediated; major acquisitions beginning to show clear per-share cash-earnings accretion; and contingent demand continuously converting into firm orders without broad delays. Conversely, if revenue continues to grow quickly in 2026-2027 but operating cash flow remains weak, contract assets and receivables continue expanding too quickly, and leverage does not fall, I would view it as a textbook case of "the story works, the investment does not."

Compared with other opportunities, my conclusion is also conservative: Compared with peers such as Ducommun and Kratos, KRMN is clearly more expensive on P/S and book multiples, while its current cash conversion is not better. Compared with a broad aerospace and defense ETF such as ITA, KRMN needs four conditions to be met at the same time in order to materially outperform: sustained high growth, successful M&A, declining leverage, and valuation that does not collapse. That path is too narrow. Compared with risk-free assets or high-grade bonds, KRMN does not offer conservative investors a sufficiently intuitive equity risk premium, because you are not buying already stable and visible cash distributions. You are betting on future execution. On the question of "if I could hold only 5 assets, would this qualify for the portfolio," my answer is: not at the current price.

Below is a simplified investment checklist conclusion:

Checklist Item Conclusion
Can I understand this business? Pass
Does it have long-term stable demand? Pass
Does it have a durable moat? Uncertain
Does it have pricing power? Uncertain
Can it generate stable free cash flow? Fail
Are its returns on capital excellent? Fail
Is management trustworthy? Uncertain
Is capital allocation rational? Uncertain
Is the balance sheet sound? Fail
Is valuation below intrinsic value? Fail
Is the margin of safety sufficient? Fail
Would long-term holding let me feel comfortable? Fail
What key facts would make me sell? Cash-flow deterioration, leverage not declining, internal-control issues not fixed, orders not converting
Am I only tempted to buy because the share price has risen or market sentiment is strong? At the current price, this point most likely needs caution

This checklist does not come from management's framing. It is an integrated judgment based on the operating, financial, valuation, and risk analysis above. The limitation to note is that the company's public history as a listed entity is not long, and M&A was frequent in 2025-2026, making some year-over-year comparisons and "organic quality" not fully comparable. Maintenance capital expenditures in Owner Earnings can also only be estimated conservatively within a range, not measured precisely.

Final Investment Conclusion

【Final Rating】 Watch

【One-Sentence Investment Thesis】 Karman Holdings is a mission-critical defense and aerospace systems supplier in attractive end markets with some engineering and qualification barriers, but its current real cash flow, balance sheet, and valuation are not yet sufficient to support a conservative long-term value investor buying heavily at the current price.

【Core Bull Points】

  • Attractive end markets: the company covers missile defense, hypersonics, tactical missiles, space launch, and newly added maritime defense, placing it in the main current of expanding U.S. defense and space spending.

  • Deep customer embedding: 130+ programs, 80+ customers, long qualification cycles, and some sole-source/single-source positions make replacement difficult.

  • Strong growth: revenue CAGR from 2023 to 2025 was about 29.6%, Q1 2026 revenue grew about 51% year over year, and backlog has exceeded USD 1 billion.

  • M&A direction has industrial logic: the 2025-2026 acquisitions were broadly centered on propulsion, nozzles, high-temperature materials, composites, and maritime defense, so the strategy is not random.

  • Large potential demand: in May 2026, the company disclosed contingent commitments from four major customers with total potential value exceeding USD 1 billion.

【Core Bear Points】

  • Operating cash flow turned negative in 2025, and free cash flow was clearly negative, showing that "growth" has not yet converted into "distributable cash flow."

  • Debt rose sharply in Q1 2026, net debt/EBITDA is elevated, and the financial buffer is not thick.

  • Material internal-control weaknesses remained unresolved as of year-end 2025, increasing financial and integration risk.

  • Book value is mainly composed of goodwill and intangible assets, tangible net worth is negative, and downside protection is poor.

  • The current valuation is far above conservative/base intrinsic value estimates and relies heavily on sustained future high growth and valuation durability.

【Key Assumptions】

  • Backlog and contingent demand can continue converting into firm orders and cash collections;

  • Seemann/MSC and other acquisitions can be integrated smoothly and materially improve the profit pool and platform capability;

  • Working-capital absorption no longer deteriorates at the pace seen in 2025;

  • Leverage gradually falls in 2026-2027 rather than continuing to rise;

  • The market remains willing to give the company a mid- to high-growth valuation in the future.

【Fair Buy Price】 I believe a more reasonable research/buy range is below USD 15-20. If one insists on a Buffett-style conservative margin of safety, the ideal buy range should be closer to USD 9-14. This is based on the combined judgment from the Owner Earnings discount model, the base-case intrinsic value range, and the asset-quality discount in this report.

【Target Holding Period】 If a suitable price appears in the future, the appropriate holding period should be at least 5-10 years. But the premise is that you are buying a platform company that is gradually delivering cash flow, not chasing a thematic story at the top of a high valuation.

【Expected Annualized Return】 The following are rough estimates based on the three scenario assumptions in this report and a 10-year holding period:

  • Bear case: about -12%/year;

  • Base case: about -4%/year;

  • Bull case: about +4% to +6%/year. These are not company guidance. They are model projections based on different Owner Earnings starting points, growth rates, and exit valuation multiples. For a high-risk growth stock, this expected return profile is not attractive.

【Maximum Loss Risk】 If order conversion falls short of expectations, M&A integration disappoints, internal-control problems drag on, and valuation multiples return to levels closer to traditional industrial companies, a 60%-80% permanent capital loss in the stock price is not unimaginable. In an extreme scenario, because tangible net worth is negative, a repricing of the "growth premium" would expose shareholders to even larger drawdowns.

【Tracking Metrics】 I will continue tracking the following indicators:

  • Operating cash flow and free cash flow;

  • Growth rates of contract assets, accounts receivable, and inventory;

  • Net debt/EBITDA;

  • EBIT interest coverage;

  • Backlog and new firm orders;

  • Conversion rate of contingent commitments;

  • Whether major customer concentration declines;

  • Whether gross margin, operating margin, and cash returns improve after acquisitions;

  • Progress in remediating material internal-control weaknesses;

  • Share dilution and the structure of new consideration.

【Signals That Would Trigger Reassessment】

  • Revenue grows rapidly for several consecutive quarters, but operating cash flow remains materially weaker than net income;

  • Major customer orders are delayed, launch schedules are cut, or contingent demand fails to materialize;

  • Net debt/EBITDA rises instead of falling;

  • Another large debt-driven acquisition occurs;

  • Material internal-control weaknesses persist beyond the end of 2026;

  • A major customer/program is lost, or a key program is insourced by the customer.

【Final Recommendation】 Put plainly, Karman belongs more on the watchlist than in a "10-year concentrated portfolio" today. If you like its industry position and long-term demand, you can keep tracking cash flow, leverage, and order conversion. But if you insist on a long-term business-owner perspective and are conservative, you should not pay today's price for a platform defense growth stock that is still proving its cash-flow quality. The conclusion is not "bad company"; it is "wrong price."

This report is based on public information and does not constitute investment advice. Markets carry risk; invest with caution.

DCOKTOSITA

DefenseMissile DefenseSpace LaunchDefense IndustryValuationValue Investing
Reader Q&A10

Baillie Framework · Ten Questions for Growth Investing

10

Hunting ten-year five-baggers among great growth stocks — pressing the upside question: "Can it get much bigger?"

Baillie Framework · Ten Questions for Growth Investing — score profile: 39/100 total Ceiling 5/10 · Revenue 2x 6/10 · Next engine 4/10 · Moat 4/10 · Reinvention 4/10 · Management 3/10 · Customer need 5/10 · Unit economics 3/10 · 5x path 2/10 · Blind spot 3/10 0510 How high is its market ceiling? Is it expanding an existing pie, or creating an entirely new market? — 5/10 Ceiling 5 Can its revenue at least double over the next five years? Is growth mainly driven by volume, price, or new businesses? — 6/10 Revenue 2x 6 After five years, what will take over as the next growth engine? Does this "second curve" exist today? — 4/10 Next engine 4 What is its core competitive advantage? Will this moat widen or narrow over the next three to five years? — 4/10 Moat 4 If its core business is disrupted, does it have the DNA to reinvent itself? How does it handle mistakes and bad news? — 4/10 Reinvention 4 Does management, especially the founder, have a long-term view and deep alignment with the company? Is it willing to sacrifice current profit for five to ten years from now? — 3/10 Management 3 If it disappeared tomorrow, how much would customers miss it? Is its growth model sustainable and not dependent on harming society or regulation? — 5/10 Customer need 5 What are the unit economics of this business, including gross margin and incremental returns? Do they improve or worsen with scale? Where does the money it earns go? — 3/10 Unit economics 3 What conditions must all hold for it to rise fivefold in 10 years? Are those conditions realistic? What expectations are embedded in today's stock price? — 2/10 5x path 2 Why has the market not realized all of this yet? Is it too hard to understand, too easy to dismiss, or too far out for investors to see? What could become the "narrative inflection point"? — 3/10 Blind spot 3
  • How high is its market ceiling? Is it expanding an existing pie, or creating an entirely new market?5/10

    Conclusion first: KRMN's ceiling has a "high absolute value, discounted quality" profile. It is mainly competing for value content and share inside an existing pie that is already expanding quickly, driven by the U.S. defense budget and commercial space launches, by relying on "mission-critical parts + qualification barriers". It is not creating a brand-new market from scratch. The track is genuinely attractive: missile defense, hypersonics, tactical missiles, and space launch are all expanding, generally at double-digit CAGRs. But demand is ultimately derivative demand governed by projects, contracts, and budgets, with policy and launch-cadence cyclicality. On Baillie Gifford's "5x in 10 years" yardstick, the ceiling dimension deserves a medium-high score: the space is large enough, growth is fast enough, and durability is supported by both budgets and launches. But this is not a platform company that "creates demand". Its blue-sky upside is constrained by "how large the procurement pool is x how much value Karman can capture", not by its ability to define the market boundary itself.

    1. Addressable-market breakdown: the absolute number is very large, but the "company view" must be separated from the "serviceable view"

    Karman's management describes its covered defense and space opportunities as a trillion-dollar-plus addressable market. To be blunt, that figure is a "total end-market pool" metric, not the portion Karman can actually consume: Karman sells subsystems such as payload protection, aerodynamic interstages, and propulsion inside missiles, interceptors, and launch vehicles. Its value per round is only a small slice of the whole missile or rocket, so the truly "serviceable" market for Karman needs a very large haircut from that total pool. A more grounded near-term anchor is the hard data confirmed by the report: ending backlog already above $1 billion, plus contingent demand commitments from four large customers with total potential value above $1 billion. That tells us the high ceiling is real, but the "height" mainly comes from a large end-market pool and remaining share-gain room, not from Karman having already locked up a proprietary trillion-dollar pie.

    2. Growth and durability across end markets: the direction is consistently upward, but third-party size estimates should be directional, not mechanically extrapolated

    Mapping the report's "three major end markets + new maritime defense" to external markets, the expansion of this pie itself is real: missile defense (integrated air and missile defense, IAMD), hypersonics, and commercial/government space launch all commonly receive double-digit annualized growth estimates from third-party market researchers, clearly faster than general industrial manufacturing. The commercial launch leg is especially steep: the report, citing the FAA's long-term forecast for 2025-2034 commercial launch and reentry activity, judges space launch growth to be positive over the long run. There is also hard evidence of policy catalysts: Karman facilities have entered the qualified supplier pool for the U.S. Missile Defense Agency's large SHIELD procurement framework, and the report also notes that the U.S. FY2027 budget request continues to add funding for missile defense and hypersonics. All of this supports the logic of "an expanding existing procurement pool, with Karman moving into the value chain". But the honest caveat is that end-market size and growth-rate ranges vary widely by methodology, so they should be treated as directional references rather than precise anchors.

    3. Key judgment: expanding an existing pie or creating a new market? Honestly, mainly the former

    Karman is competing for value content and share inside an existing pie that is already expanding quickly. It is not creating an entirely new market. Three reasons, without inflating the growth narrative:

    1. Demand is derivative and determined by budgets and launch cadence, not created by Karman itself. The report says it directly: the three major markets "remain project-based, contract-based, budget-based demand" and "do not mean revenue is as stable as a utility". Its ceiling is determined by "how large the U.S. defense budget pool is + how fast commercial/government launches occur x how much value Karman can capture". This is positioned growth carried by upstream waves, not the definition and creation of a previously nonexistent market.

    2. Share-gain room is a real source of ceiling, but it comes from "qualification + sole/single-source positioning" that lets Karman eat into existing value content. The report notes 130+ production/R&D programs, 80+ customers, some sole/single-source positions, and expensive, lengthy requalification. That means each new program win lets Karman bite off more value from the existing pie. What expands is "Karman's share within the existing pool", not the species of the pie itself.

    3. Policy exposure and cyclicality are explicit, so upside is not unconstrained. Demand is concentrated among a few large prime contractors and government customers: the report says the top three customers accounted for more than half of 2025 revenue. Contingent demand also means "high demand does not equal billable, collectible firm contracts". If budget approvals, launch cadence, or technology roadmaps shift, the "realizable portion" of the ceiling can be compressed. This is structurally different from the great growth stocks Baillie Gifford prefers, where companies create demand themselves, network effects reinforce themselves, and the company defines the demand curve.

    4. Ceiling conclusion from a Baillie Gifford lens

    Using the LTGG yardstick: Karman passes on the ceiling's "space x growth x durability" dimensions: multiple double-digit-growth defense/space themes overlap, both policy and launch activity are adding support, and the share-gain path is clear enough to justify the "good end market" judgment. But the ceiling's "quality" needs a discount: this is derivative demand driven by upstream budgets and launch waves, value content is capped by share per round, and policy cycles matter. It lacks the blue-sky quality Baillie Gifford values most: "creating and defining an entirely new market itself". Put differently, the market ceiling is high enough for a well-executing subsystem supplier to generate meaningful growth. The report measures a 2023-2025 revenue CAGR of about 29.6% and 2026Q1 year-over-year growth of +51%. But the ceiling itself is not the rarest or most compelling link in a "5x in 10 years" story. It offers medium-high-certainty growth from "continually gaining share in a large, expanding, high-certainty pie", not the nonlinear breakout of "drawing a new pie". This also matches the report's overall rating of "good end market, bad price" (Watch): the ceiling can support growth, but whether that growth is worth the current high valuation of about $52.81 per share and a market cap of about $6.87 billion is a separate question beyond Q1.

    Jun 5, 2026
  • Can its revenue at least double over the next five years? Is growth mainly driven by volume, price, or new businesses?6/10

    Conclusion first: revenue is very likely to "at least double" over the next five years, from about $470 million to about $940 million+. At the recent three-year compound growth rate of about 29.6%, it would take only about 2.5 years to double, so the hurdle is very low. In fact, the company's raised 2026 guidance already points to revenue above about $720 million, or about +54% year over year, leaving it only one step away from doubling. But using Baillie Gifford LTGG standards to ask "what drives this growth, and whether the growth quality fits a great growth stock", a discount is necessary: top-line doubling can hold, but the driver mix relies heavily on debt-funded acquisitions + nonlinear project-based demand. The organic, compounding quality is insufficient.

    1. Five-year doubling: arithmetically, there is little suspense

    The report gives revenue for 2023/24/25 as $280.7 million / $345.3 million / $471.5 million, with a two-year CAGR of about 29.6%. 2026Q1 revenue was $151.2 million, up +51% from 2025Q1's $100.1 million. Moving from about $470 million to about $940 million requires only about 2.5 years at a 29.6% compound rate.

    The more direct anchor is the company's raised full-year 2026 guidance: revenue is expected to exceed about $720 million, up about +54% year over year. Management also said Q1 revenue plus the portion of ending backlog expected to convert within the year already covers most of the raised full-year guidance, giving fairly high visibility. In other words, one year alone pushes the base above $700 million; from there, even a 15% growth rate would carry revenue past $940 million around 2028. So on the question of "can revenue at least double in five years", the answer is yes, and it will likely happen earlier, within about 2-3 years. Baillie Gifford would say: doubling is not the issue. The issues are whether it can keep doubling after that, and whether the doubling comes from sustainable engines.

    2. Three-engine breakdown: volume, price, and new businesses

    1) Volume (programs / launch cadence): the base engine, but demand is project-based and nonlinear. In 2025 the company supported 130+ production/R&D programs and 80+ customers, with exposure to three major end markets: hypersonics and strategic missile defense, tactical missiles and integrated defense, and space and launch. Demand tailwinds are real: the U.S. FY2027 budget continues to add funding for missile defense and hypersonics, and the FAA also forecasts long-term expansion in 2025-2034 commercial space launch activity. Ending backlog above $1 billion provides tangible visibility for "volume". But the honest point is essential: this is project-based, contract-based, budget-based demand, not linear subscription revenue "like a utility". It can move with prime-contractor order timing, launch timing, budget approvals, and technology-roadmap changes. If a prime's firm order or launch cadence is delayed, revenue can turn before cash collections do. Volume is a real engine, but it is more volatile than the "structural penetration increase" growth Baillie Gifford prefers.

    2) Price (mix upgrade + pricing/execution): helpful, but limited in size. Gross margin rose from 37.6% → 38.3% → 40.3% from 2023 to 2025, reflecting a shift toward higher-value mission-critical systems, better pricing, and better execution quality. But "price" is a secondary direct contributor to top-line doubling: it mainly improves margins, not revenue scale. And a cold-water caveat is needed: the report points out that 2025 operating margin actually fell from 18.4% to 15.5%, while net margin was only about 3.7%; gross-margin improvement did not pass smoothly through to the bottom line. Price is a "quality engine", not the "doubling engine".

    3) New businesses (M&A): the growth "accelerator", and also the part that deserves the largest discount. This is the most underappreciated contributor to doubling among the three engines, yet also the one that deserves the most caution. The report discloses that 2025 acquisitions of MTI / ISP / Five Axis produced net cash outflow of about $211.9 million. In 2026Q1 the company then acquired Seemann Composites and Materials Sciences for about $232.8 million, adding an entire maritime-defense end-market exposure, mainly financed with new borrowings. In other words, a meaningful portion of the +54% growth in 2026 is "bought revenue", not organic growth. The cost is visible: total debt rose from $580.5 million at the end of 2025 to $855.5 million in 2026Q1, with net debt/EBITDA of about 3.7-5.4x; 2025 operating cash flow turned negative at -$22.12 million, while contract assets increased by $49.08 million. Growth is consuming working capital.

    Concluding split, from a Baillie Gifford lens: five-year doubling = organic volume growth (the base, likely the largest component, but nonlinear) + mix upgrade (margin improvement, small contribution to revenue scale) + frequent debt-funded acquisitions (materially amplifying reported growth, but diluting growth quality). The doubling mainly stands on two legs: "volume + new businesses", and the "new businesses" leg is grown with borrowed money.

    3. Full honesty: which signals should not be counted as hard evidence for doubling

    • Contingent demand ≠ firm contracts. In May 2026 the company disclosed contingent demand commitments from four large customers with total potential value above $1 billion. That sounds powerful, but the report clearly calls them "contingent demand commitments", not signed, billable, collectible firm orders. Baillie Gifford does look for upside, but upside must rest on a verified demand base, not treating contingent commitments as certain revenue.

    • Customer/supplier concentration is high. The top three customers accounted for 28.5% / 12.8% / 10.2% of 2025 revenue, more than half in total; the top two customers accounted for 25.6% / 11.6% in 2026Q1; a single supplier accounted for about 23.8% of accounts payable. Any large-program delay or customer make-or-buy shift toward insourcing would directly hit the volume engine.

    • Cash quality of growth is weak. 2025 free cash flow was about -$42.46 million, and 2026Q1 operating cash flow was only $0.209 million. If revenue doubling continues through a pattern of "the larger it gets, the more cash it needs + the more it buys, the more leverage it adds", that is a negative for the "10-year compounding" Baillie Gifford truly cares about, because it requires ongoing external financing to continue, while dilution and debt risk accumulate.

    4. Final judgment for Baillie Gifford (LTGG)

    "Revenue at least doubles over the next five years": yes, and likely earlier, in about 2-3 years. Quantitatively, this question carries little suspense. But when the growth structure is laid out, Baillie Gifford would have two reservations:

    1. The driver mix deserves a discount. Doubling is mainly driven jointly by "organic volume growth (programs/launches, nonlinear and controlled by budgets and order timing)" and "debt-funded acquisitions (bought revenue)". "Price/mix upgrade" mostly improves margins rather than scale. This is not Baillie Gifford's favorite form of pure organic growth, where a single product naturally compounds through structural penetration into a huge TAM.

    2. Doubling ≠ great growth. Doubling revenue is easy; the hard part is whether it can continue after doubling and convert revenue into compounding free cash flow. At this stage, Karman is a platform-style defense growth stock that is "using debt and acquisitions to grow revenue, while cash flow remains unproven". In the context of the Baillie Gifford ten questions, Q2 can be marked as "quantity achieved, quality still unproven". It clears the top-line doubling hurdle easily, but whether it can become a "5x-in-10-years great growth stock" (Q9) depends less on whether it can double and more on whether the Q4 moat and Q8 unit economics/cash conversion catch up. Combined with the report's Watch rating, this matches the core risk judgment: growth can continue, but shareholder returns may still be poor.

    Jun 5, 2026
  • After five years, what will take over as the next growth engine? Does this "second curve" exist today?4/10

    Conclusion first: under Baillie Gifford's strict standard for an "independent second engine", KRMN does not have a physically independent second curve today that can truly take over after the main curve peaks. What it has is an "end-market diversification puzzle" inside the same main curve: U.S. defense/space procurement. It looks more like an extension of core customers and markets than an internally incubated new engine driven by different demand and capable of independently carrying growth. The implicit premise of this chained question needs to be stated up front: Q3 is not asking whether the company has other revenue sources. It asks, after the main curve of high growth in missile defense/hypersonics/tactical missiles naturally slows, TAM penetration peaks, and the acquisition puzzle has no more obvious pieces, who takes over, and what physically independent demand driver powers that handoff. Measured by that standard, KRMN's current candidates do not satisfy the word "independent".

    First, look at the pieces currently used in KRMN's "second curve" narrative, and test each against the Baillie Gifford standard:

    Candidate 1: growth in commercial/government space launches. This is the piece that comes closest to having a "second curve" character. The report lists "space and launch" as one of the three major end markets. In 2026Q1 the company said this segment led growth across end markets, driven by the timing of orders for critical content for traditional and emerging launch providers and spacecraft. On the surface, it is exposed to a demand curve different from defense procurement: commercial space launch volumes should rise over the long run, and the report also cites the FAA's forecast for expanding 2025-2034 commercial launch/reentry activity. But under Baillie Gifford standards it still does not qualify as an "independent second engine": first, based on today's active opportunity pipeline, space and launch is only a smaller piece, clearly smaller than the two defense core businesses, hypersonics/strategic missile defense and tactical missiles/integrated defense, combined; second, the report makes clear that KRMN sells the same integrated "design-test-qualification-manufacturing" capabilities in payload protection, interstages, and propulsion. Space launch is the same capability with a different customer interface. It is not a new engine; it is the old engine moved to another engine bay; third, it remains project revenue driven by "order timing", not a self-reinforcing flywheel that can compound independently from the main curve.

    Candidate 2: a new maritime-defense platform from the Seemann/MSC acquisitions. The report is explicit: after the 2026Q1 consolidation of Seemann Composites and Materials Sciences, KRMN added maritime exposure, including submarines, UUV/USV, and strategic surface vessels, for total consideration of about $232.8 million, mainly financed with new borrowings. This is precisely the kind of "false second curve" that Baillie Gifford standards should treat cautiously. First, it was not internally incubated; it was bought with debt. The report has already documented the company's pattern of "first building a platform, then continuously acquiring capabilities": MTI/ISP/Five Axis produced net cash outflow of about $211.9 million in 2025, net debt/EBITDA rose to about 5.4x, and tangible net worth turned negative. Capability expansion assembled with leverage is essentially capital operation, not engine reinvention. Second, the demand side is still the U.S. Department of Defense, in the same TAM as the main curve and driven by the same defense budget: naval-vessel budgets and missile-defense budgets rise and fall together, so it is not "physically independent with uncorrelated risk". Third, it is the smallest pipeline piece among the four end markets, and the company describes its value more in "unique production capabilities", such as resin infusion, automated fiber placement, and 3D printing, than in an end market that can independently carry growth. This is classic capability/end-market diversification, not a "second growth engine".

    Candidate 3: hypersonic production ramp. This is not a second curve at all. The report lists "hypersonics and strategic missile defense" as one of the three pillars of the main curve itself. Calling it the successor would mean using one pillar of the main curve to take over after the main curve peaks, which is logically self-contradictory.

    Candidate 4: new capabilities from acquisition pieces, including composites, high-temperature materials, nozzles, and propulsion. The report has already described these acquisitions as "adding capabilities around high-temperature materials, propulsion, nozzles, composites, and maritime defense, with consistent industrial logic". Precisely because the industrial logic is consistent, they prove these are not independent second curves. They widen the moat of the same main curve and deepen wallet share with the same prime customers. The second curve Baillie Gifford wants is like Amazon growing AWS out of e-commerce: a new species driven by different demand, different customers, and different physical logic. At KRMN, this is all depth in "supplying more critical content to the same missile/space programs", not a horizontal new species.

    Using Baillie Gifford's four tests for an "independent second engine", the overall verdict is:

    • Is demand independent? No. Most demand across the four end markets, including maritime and space launch, is driven by U.S. defense/space procurement budgets. The company's FY2026 revenue guidance is broadly tied to the same budget cycle, and the report repeatedly emphasizes this is "project-based, contract-based, budget-based" demand.
    • Was it internally incubated? Mostly no. The capability expansion documented in the report relies heavily on frequent debt-funded acquisitions, not a new business grown internally.
    • Is it physically independent and able to stand alone after the main curve peaks? No. Space launch is the closest candidate, but it is far too small today to carry growth independently if the two core defense businesses roll over.
    • Is it a new self-reinforcing flywheel? No. All candidates still reuse the same "qualification-embedding-delivery" capability set. This is moat widening, not flywheel replacement.

    Honest conclusion from a Baillie Gifford lens: Baillie Gifford looks for great growth stocks that can deliver "5x in 10 years", where a second engine ignites after the main curve peaks. KRMN today has strong "main-curve depth + end-market diversification", but it does not have a qualifying physically independent second curve. Its "multi-market" profile mostly reduces single-program volatility through customer/end-market dispersion: the report notes no single program exceeded 12% of revenue in 2025, with 80+ customers and 130+ programs. It is not the structure of "another engine taking over when the main curve ebbs". Treating these pieces as a second curve is exactly the narrative inflation risk the report repeatedly warns against: revenue is still growing quickly, with a 2023-2025 CAGR of about 29.6%, 2026Q1 year-over-year growth of about 51%, and backlog above $1 billion, but all growth still runs along the same budget-driven main curve and is fed by working capital and leverage: 2025 operating cash flow turned negative, free cash flow was about -$42.46 million, and net debt/EBITDA was about 5.4x. For Baillie Gifford, that means when the U.S. defense/space procurement main curve naturally slows, there is no visible independent second curve already ignited and waiting. The more likely handoff is still "buying capabilities and gaining share on the same main curve", a method with limits that becomes more expensive and more leveraged over time. At the current price of about $52.81 and market cap of about $7.0 billion, and about 229x conservative Owner Earnings, the market has already prepaid for "sustained high growth on the main curve + smooth multi-end-market execution". It is not paying for a truly independent second curve, because strictly speaking, one does not exist today. KRMN fails this second-curve question; that is one reason the rating is Watch, not Buy.

    Jun 5, 2026
  • What is its core competitive advantage? Will this moat widen or narrow over the next three to five years?4/10

    Conclusion first: Karman's moat is essentially a combined "relationship/execution" barrier made of engineering capability + program qualification + process/materials IP + sole-source embedding + switching costs, not brand or network effects. The report scores its strength at 3/5: real and effective, but not yet very wide. Over the next 3-5 years, I judge that its "absolute width" will probably widen, while its relative advantage may not widen at the same pace. Stickiness in individual qualified programs should deepen with delivery history, and defense capacity expansion is a tailwind. But the barrier is more about manufacturing execution + qualification than proprietary technology. Add the primes' make-or-buy option and the dependence of the "acquisition puzzle" on capital operations, and it is hard for this moat to evolve into a self-reinforcing wide moat. From a Baillie Gifford lens, this is a "medium moat, trend not yet proven" case, with slight tilt toward widening but requiring cash-flow and integration proof to refute the bear case.

    Moat essence: qualification + sole-source embedding as an execution barrier

    Karman does not sell commodity parts. It sells mission-critical links after integrated "design-test-qualification-volume production": payload protection and deployment systems, aerodynamic interstage systems, and propulsion systems used in high-priority programs such as missile defense, hypersonics, tactical missiles, and space launch. The report notes 130+ production/R&D programs and 80+ customers in 2025. This moat is twisted together from several forces:

    • Program qualification + switching costs: the report says Karman is in a sole/single-source position on many programs. Once qualification is complete and deliveries are stable, prime contractors usually do not lightly restart a "lengthy and expensive requalification process". Public disclosures indicate that the vast majority of Karman's revenue comes from sole/single-source contracts, and these strategic missile and space programs often last decades. Long program lives plus requalification costs mean that once Karman is on the platform, stickiness is real.
    • Process and materials know-how (IP): the report lists Design IP, Proprietary IP, and Process IP, plus capabilities strengthened through 2025-2026 acquisitions in high-temperature materials, nozzles, and composites.
    • Embedded customer relationships: the barrier is not "consumers cannot live without the brand", but "primes have no reason to risk redoing qualification and system integration". This is a typical relationship + execution barrier.

    On Baillie Gifford's moat scale, these forces put Karman in the "high switching costs + regulatory/qualification threshold" category. It is real, but it comes from "the customer's cost to redo work is high", not from "nobody else can ever build what we build". That is the key dividing line for judging whether the moat widens or narrows over time.

    Next 3-5 years: honest accounting of forces in both directions

    Widening forces, which make me lean slightly positive:

    • Program embedding deepens with delivery history: across program lifecycles that can last decades, every additional year of Karman delivery raises the opportunity cost of requalification for the prime, so stickiness in installed programs naturally widens.
    • Qualification stickiness + new-contract positioning: in early 2026, Karman facilities secured a qualified-supplier position in the U.S. Missile Defense Agency's large SHIELD procurement framework, giving it another entry point to "qualify first, then become sole-source" in next-generation missile-defense programs.
    • Defense capacity-expansion tailwind + breadth of integrated capabilities: the report scores industry attractiveness at 4/5, and the U.S. FY2027 budget continues to add funding for missile defense/hypersonics. Karman is also exposed to both defense restocking and commercial space launch. Acquisitions have broadened the capability puzzle across propulsion, nozzles, high-temperature materials, composites, and maritime defense. The report also confirms backlog above $1 billion and May 2026 disclosure of four large customers with potential demand above $1 billion.

    Narrowing forces, which keep me from upgrading the judgment:

    • The barrier is more "manufacturing execution/qualification" than proprietary technology: the report explicitly says the moat "exists and is effective, but cannot yet be called very wide", and competition remains. Parts/subsystem suppliers can move upward, while primes always face the make-or-buy question. Karman is a specialized subsystem supplier and lacks the end-to-end platform-integration market power of a prime. A barrier based on "high customer redo costs" has a lower ceiling than one based on "others cannot build this technologically".
    • The "acquisition-puzzle" nature of capability improvement means dependence on capital operations: the report repeatedly emphasizes that part of the integrated capability investors see "comes from capital operations, not entirely from organic growth within a standalone enterprise". This ties the moat's sustainability to capital markets and integration execution. At the same time, the report reveals net debt/EBITDA of about 5.4x, negative 2025 operating cash flow (-$22.12 million), negative tangible net worth, and unresolved material internal-control weaknesses at the end of 2025. A moat bought with leverage can loosen if the financing environment or integration synergies change. That is far from Baillie Gifford's preferred "organic, self-reinforcing" moat.
    • Budget / program cadence / technology-roadmap risk: demand is project-based, contract-based, and budget-based, not utility-stable. The report warns that "high demand ≠ high-quality, collectible firm contracts". If final prime orders, launch cadence, or budget approvals are delayed, Karman's pre-investment in capacity happens before cash collection. If the technology roadmap shifts, such as one interceptor generation or launch configuration being replaced, a qualified position can lose value.
    • Customer concentration magnifies single-point fragility: the top three customers accounted for 28.5% / 12.8% / 10.2% of 2025 revenue. At the level of a single large customer, the "width" of the moat is actually narrow but deep: losing one large program creates a deep wound.

    Baillie Gifford conclusion

    Baillie Gifford wants a compounding barrier where the moat deepens with scale and embedding over 10 years, making it harder for competitors to catch up. Karman has a real medium moat: qualification stickiness, decades-long program lives, sole-source embedding, and defense capacity-expansion tailwinds mean the "absolute width" should probably deepen over the next 3-5 years. But it is not a moat that automatically widens until competitors cannot catch it. The barrier source is more "customer redo cost" than proprietary technology; much of the incremental width is bought through acquisitions and leverage rather than organic dominance; and it depends on cash-flow realization, successful integration, and no adverse budget/technology-roadmap shift, all of which remain unproven.

    So my judgment is "medium moat, trend unproven, with a slight tilt toward widening but needing cash-flow and integration proof". If operating cash flow keeps recovering through 2026-2027, net debt/EBITDA falls below 2.5x, acquisitions begin adding per-share cash earnings, and contingent demand converts into firm orders, the moat will be proven to be "organically deepening" and Baillie Gifford could upgrade it. Conversely, if revenue keeps growing quickly while cash flow remains weak, leverage does not fall, and contract assets keep expanding too fast, this moat will look more like an "execution barrier maintained by capital operations", with unsustainable widening. That is consistent with the report's cautious moat score of 3/5 and checklist item "does it have a durable moat = uncertain". It is important to remember this is a single moat-dimension judgment and does not constitute a Buy conclusion: the report's overall rating is Watch, and whether the moat is real is separate from whether the current price is safe, with the stock around $52 and already down about 56% from a 52-week high of about $118.

    Jun 5, 2026
  • If its core business is disrupted, does it have the DNA to reinvent itself? How does it handle mistakes and bad news?4/10

    Conclusion first: under Baillie Gifford LTGG's "reinvention DNA" lens, Karman Holdings is currently neutral to slightly weak. It has shown external adaptability through "using capital operations to reshape its capability portfolio", a roll-up style of evolution. But there is still no verifiable record proving that it can actively transform after core disruption or achieve an internally R&D-driven paradigm shift. Its culture around mistakes and bad news is mixed: proactively disclosing material internal-control weaknesses, customer concentration, and negative cash flow is positive, but the fact that the internal-control weaknesses themselves remain unresolved, plus the roll-up culture left by private-equity platform building, is a clear negative. This is a company with a short history as a listed entity: it was formed not long ago and only IPO'd in 2025. It has not yet gone through a true test in which its core was disrupted, so the evidence line Baillie Gifford wants around "reinvention under adversity" is basically blank today.

    First, state the hidden premise of this chained question explicitly. What Baillie Gifford's Q5 is really asking is: if one of Karman's core subsystems, such as a payload-protection system, aerodynamic interstage, or propulsion system, is disrupted by a technology-roadmap shift, or is internalized by a large prime contractor through a make-or-buy decision, does the company have the DNA for active transformation and a culture of honest error correction? The report itself names exactly these two disruptions as top risks. The first item in the risk list is competition and customer insourcing risk: "whether customers make it themselves or outsource it is a continuing choice; parts/subsystem suppliers may also move upward". The second is order conversion and technology-roadmap risk. So this is not hypothetical; it is a real threat identified by the report.

    Reinvention DNA: external adaptability exists, but there is no evidence of an internal paradigm shift.

    Karman's demonstrated "reinvention" is essentially building capabilities through acquisitions, not achieving a generational technology shift through internal R&D. The report describes the capital-allocation path very directly: "first build a platform, then continue acquiring capabilities". It completed three acquisitions in 2025, MTI, ISP, and Five Axis, with net cash outflow of about $211.9 million. In 2026Q1 it then acquired Seemann Composites and Materials Sciences for total consideration of about $232.8 million, expanding its capability map from legacy subsystems into high-temperature materials, propulsion, nozzles, composites, and maritime defense. This is indeed a form of "portfolio reshaping" ability: end markets expanded from hypersonics/strategic missile defense, tactical missiles, and space launch to include maritime defense exposure in 2026Q1. Put differently, if one product line cools, it has flexibility to "buy into the next capability curve". That adaptability is real.

    But from Baillie Gifford's standard, this adaptability carries three hard discounts:

    First, it is more external than internal. The reinvention Baillie Gifford truly admires is a company using its own R&D and culture to complete a paradigm shift: Amazon from retail to cloud, Nvidia from gaming to accelerated computing. In Karman's case, "part of the integrated capability investors see comes from capital operations, not entirely from organic growth within a standalone enterprise", in the report's own words. Bought capabilities have a weaker self-reinforcing moat quality, which is why the report gives the moat only 3/5: "it exists and is effective, but cannot yet be called very wide".

    Second, there is not yet any record of active transformation after core disruption. Karman was formed not long ago and only IPO'd in 2025. Its public history is very short, and the report explicitly notes that "the company does not have a long comparable public-company history". It has not yet experienced a real test in which a technology generation made a core subsystem obsolete and forced active transformation. So the evidence line Baillie Gifford wants for reinvention under adversity is currently not verifiable. It can only be counted as "potential capability", not "proven capability".

    Third, the new CEO has only just taken office, so transformation decisiveness is unknown. Jon Rambeau took over in March 2026. He is a seasoned defense executive from Lockheed Martin and L3Harris, and his background fits Karman's qualification-intensive, project-based business, which is positive. But after former CEO Tony Koblinski retired and remained on the board, investors are facing a combination of "new CEO + old platform + continued frequent acquisitions". Whether the new leader can add internal reinvention capability beyond "continuing the roll-up" still needs time. The report judges that "management stability and the long-term performance record are still forming".

    Handling mistakes and bad news: transparent disclosure is positive, but unresolved controls + roll-up culture are negative.

    This dimension is genuinely mixed and must be considered from both sides:

    Positive: signs of honest bad-news disclosure. Karman has not pretended everything is fine. In its 2025 10-K it proactively acknowledged material weaknesses in internal control as of December 31, 2025, including insufficient maintenance of COSO components, insufficient IT general controls, and significant business-process-level control gaps. It also disclosed a phased remediation plan. Likewise, the report notes that the company plainly disclosed unfavorable facts including customer concentration (the top three customers at 28.5%, 12.8%, and 10.2% of 2025 revenue), a single supplier accounting for about 23.8% of accounts payable, 2025 operating cash flow turning negative (-$22.12 million), and free cash flow of about -$42.46 million. A company willing to put bad news on the table, rather than hide it, has at least a passing base for an "honest correction culture". The report also explicitly says "no direct evidence of financial fraud has been seen so far".

    Negative: substantive gaps in correction culture. But "disclosing the problem" is not the same as "fixing the problem". The most visible negative is that material internal-control weaknesses remained unresolved at the end of 2025. The remediation plan must be fully implemented, tested, and validated before operating effectiveness can be confirmed, which means that at the time of writing this red light was still on. For a company that recently IPO'd, depends on acquisition integration, and is rapidly changing its financial structure, the real test of correction culture is speed and execution, and that has not yet been delivered. The report therefore lists this as a bear-case reason and explicitly names "remediation progress on material internal-control weaknesses" and "material internal-control weaknesses continuing beyond the end of 2026" as tracking indicators and reassessment triggers. In addition, the report notes that the company "from the beginning carried clear traces of private-equity platform transformation, rather than the traditional culture of an old high-quality public company compounding over the long term". The former CEO received about $5.257 million in cash bonuses from Phantom Units after the IPO, and directors and executives together owned only about 5.77%. This PE roll-up DNA is distant from Baillie Gifford's preferred founder/long-term-owner culture, deep alignment, and treating bad news as fuel for compounding learning.

    Honest overall assessment for Baillie Gifford. Baillie Gifford wants a great growth company that can reinvent itself in years 3-10 and turn each mistake into learning compounding. What Karman can offer today is external adaptability through "using capital to buy the next capability curve" plus acceptable honesty through "willingness to disclose bad news". It cannot yet prove paradigm-shift DNA for internally driven active transformation after core disruption, and it has not yet proven its corrective execution culture through quickly remediating material internal-control weaknesses. Combined with the report's overall Watch rating and the judgment that the current price of about $52 is far above reasonable intrinsic value of $13-20, this dimension can only be scored neutral to slightly weak: it has the "tools" of reinvention, meaning acquisition flexibility, but lacks the "evidence", meaning an internal transformation record; it has the "attitude" of correction, meaning transparent disclosure, but lacks the "result", meaning remediated weaknesses. The facts that could lift this score are those named by the report: internal-control weaknesses remediated before the end of 2026, acquisitions beginning to deliver per-share cash accretion, and the new CEO building internal capability beyond a roll-up. Until those facts appear, Karman's "reinvention DNA" remains "unproven" from a Baillie Gifford lens.

    Jun 5, 2026
  • Does management, especially the founder, have a long-term view and deep alignment with the company? Is it willing to sacrifice current profit for five to ten years from now?3/10

    Conclusion first: this is not Baillie Gifford's favored archetype of "founder-led for the long term, deeply aligned interests, and willingness to sacrifice current profit for five to ten years out". The "investment for the future" side of long-term thinking does exist, but founder-style alignment is weak, governance has hard flaws, and the new management team's long-term record has not yet formed. Through a Baillie Gifford lens, this should be judged weak, at best neutral to slightly weak. Karman has made substantive moves to "spend for the future", but it lacks the two foundations Baillie Gifford values most: a captain with deep skin in the game who can span a 10-year cycle, and a governance base that can pass a trust test.

    First, why the "founder alignment" test does not pass. Karman has no founder control in the traditional sense. It is a company that came to IPO with clear signs of a private-equity platform transformation, a PE-controlled roll-up platform. It has no dual-class voting rights and no family- or founder-locked control structure. The report discloses that in the 2026 proxy, directors and executives together owned only about 5.77%, and that ownership was fragmented: former CEO Tony Koblinski had about 1.75%, director David Stinnett about 2.64%, while CFO Mike Willis and COO Jonathan Beaudoin each had less than 1%. Alignment "exists but is not strong", and I agree with that report judgment. For Baillie Gifford, the ideal is an operator with most of their net worth in the company, sitting in the same boat as outside shareholders to the point where they cannot afford to be wrong. Karman is far from that standard.

    The new CEO further discounts long-term assessability. Current CEO Jon Rambeau formally took office in March 2026, replacing Koblinski, who retired but stayed on the board. Rambeau has a substantial industry background: about 26 years at Lockheed Martin, including missile defense/electronic warfare/F-35 international programs, then work at L3Harris. That is positive for whether he can manage the platform. But his compensation structure is a double-edged sword for long-term alignment: base salary + target annual cash bonus + annual equity incentives, plus a one-time RSU that vests after three years. The three-year lock-up does push him toward the medium term, but this is granted equity incentive, not personally purchased real-money ownership. It is different from Baillie Gifford's preferred "founder investing their own wealth for the long term". The combined situation is what the report calls "new CEO + old platform + continuation of frequent acquisitions": stability and the long-term performance record are still forming, so visibility is low from a Baillie Gifford lens.

    Governance flaws are the most damaging negative. In its 2025 10-K, the company admitted that as of December 31, 2025, it had material weaknesses in internal control, including insufficient maintenance of COSO components, insufficient IT general controls, and missing controls at key business-process levels. These had not been remediated as of the report's publication. This does not equal fraud, but for a recently IPO'd company that is scaling rapidly through acquisitions and undergoing sharp financial-structure changes, material internal-control weaknesses directly weaken confidence in "reporting quality" and "management spending capital clearly". That conflicts with Baillie Gifford's requirement for a governance base worthy of long-term stewardship. Add two "cash-out" signals: the July 2025 secondary offering was essentially old shareholders selling, with the company receiving no new operating capital; and the former CEO received about $5.257 million in cash bonuses from Phantom Units after the IPO. These arrangements are not necessarily unreasonable, but they point to a PE platform culture rather than the "old high-quality public company compounding patiently for the long term" character Baillie Gifford prefers.

    What about willingness to sacrifice current profit for five to ten years out? It exists, but the qualification matters. Karman has certainly been spending heavily "for the future". The report shows that in 2025 it completed three acquisitions, MTI, ISP, and Five Axis, with net cash outflow of about $211.9 million. In 2026Q1 it acquired Seemann Composites and Materials Sciences for about $232.8 million, mainly using new borrowings. More direct evidence of "sacrificing the current period" is cash flow: 2025 operating cash flow was about -$22.12 million, and free cash flow was about -$42.46 million, mainly because contract assets increased by $49.08 million and receivables increased by $18.36 million, among other working-capital uses, combined with ongoing capex. In other words, management is indeed subordinating current cash flow to capacity expansion, capability additions, and order capture. The positive point is that the acquisition direction has industrial logic and is not random patchwork: it strengthens high-temperature materials, propulsion, nozzles, composites, and maritime defense, consistent with the existing payload-protection/aerodynamic-interstage/propulsion platform. That is a form of long-term investment Baillie Gifford would recognize.

    But Baillie Gifford would immediately ask: can the investment truly translate into long-term per-share value? This has not been proven. The report is precise: the issue is not direction, but "buying quickly, buying a lot, and whether what is bought can turn into real per-share cash earnings". So far this has not been sufficiently proven. Meanwhile, net debt/EBITDA is about 5.4x, interest coverage only about 1.6x, and tangible net worth is negative. Baillie Gifford is willing to tolerate losses and even deliberate sacrifice of current profit for the long term, but only when unit economics and the end state are clear, and management has a credible record of turning investment into compounding. Karman is "investment already made, results not yet delivered, executor just changed, governance still impaired". The difference from "Amazon-style sacrifice today for 10 years from now" is that Amazon's model was founder-led, had a visible record, and a self-reinforcing moat; Karman looks more like a PE platform using leverage to accelerate integration, with long-term value creation still a bet rather than a verified fact.

    Baillie Gifford overall judgment: weak, roughly the report's cautious 3/5, perhaps lower. Positives include "long-term investment with industrial logic + willingness to let current cash flow give way to expansion + a new CEO with solid industry experience + limited medium-term alignment through a one-time three-year RSU". The heavier negatives are: no founder control, directors and executives owning only about 5.77% in aggregate and fragmented, PE roll-up platform culture, including frequent debt-funded acquisitions + old-shareholder secondary-sale cash-outs + Phantom Units cash bonus, unresolved material internal-control weaknesses, and no long-term record for the new CEO. For a growth investor who prizes founder qualities and deep interest alignment, Karman cannot give a convincing "Yes" on this question. It has the actions of long-termism, but lacks the person, alignment, and governance credibility of long-termism. Within the overall Watch rating framework, this question is an important vote for "Watch rather than Buy": narrative-heavy long-term spending cannot cover the three hard constraints of weak alignment, governance flaws, and an unproven record.

    Jun 5, 2026
  • If it disappeared tomorrow, how much would customers miss it? Is its growth model sustainable and not dependent on harming society or regulation?5/10

    Conclusion first: stickiness passes; sustainability deserves a discount. From a Baillie Gifford lens, this is "neutral to positive". If Karman disappeared tomorrow, a few leading prime contractors would indeed "miss it badly" in the short term: it is embedded in 130+ programs, holds sole/single-source positions, requalification is "lengthy and expensive", and primes have no reason to risk restarting qualification for already qualified, stable-delivery links. That switching-cost layer is a real moat. But the question of whether the growth model is sustainable needs an honest discount: its indispensability is heavily built on a few large customers + defense budgets + derivative demand. This is an indispensability that can be punctured at single points, not a dispersed, self-sustaining indispensability. Socially and regulatorily, it is part of a legal mainstream defense supply chain; its growth is not based on predatory subsidies or consumer harm, but it carries the policy coloration of defense, export controls, and ethical debate.

    Layer 1: customer indispensability and switching costs, which pass

    The report's description of stickiness is solid: Karman does not sell commodity parts. It sells mission-critical links embedded in missile defense, interception, launch, and similar systems after integrated "design-test-qualification-manufacturing". In 2025 it supported 130+ production/R&D programs and served 80+ customers, and no single program averaged more than 12% of revenue in 2024 or 2025. The moat is defined by the report as a combined barrier of "engineering capability, program qualification, process IP, materials/manufacturing know-how, and switching costs". The key is not "consumers cannot live without the brand", but "prime contractors have no reason to risk redoing qualification and system integration". Public disclosures indicate that once a supplier is qualified on a program and delivers stably, customers usually do not restart a long and expensive requalification process.

    So the answer to "how much would customers miss it tomorrow" is: for the deeply embedded programs, primes would miss it a lot and could not switch quickly. That is exactly the "effective" half of the report's moat score of 3/5, where the moat "exists and is effective, but cannot yet be called very wide".

    Layer 2: but indispensability is concentrated, so sustainability is discounted

    Baillie Gifford is not only asking "is it sticky now", but "can that stickiness support long-term growth". Here the report's data require an honest downgrade:

    • Customer concentration is high. The top three customers accounted for 28.5%, 12.8%, and 10.2% of 2025 revenue, more than half combined; in 2026Q1, the top two customers accounted for 25.6% and 11.6%; at the supply-chain end, a single supplier accounted for about 23.8% of accounts payable at the end of 2025. That means its "indispensability" is indispensability to a few counterparties. The report says directly that "demand is not unpredictable, but it is not dispersed". Any large-program delay, acceptance issue, or customer insourcing decision through make-or-buy will be magnified.
    • Derivative demand, project-based and budget-based. Revenue is "project-based, contract-based, budget-based" demand, not utility-stable cash flow. It depends simultaneously on defense-budget expansion/contraction and prime-contractor order cadence. This kind of stickiness is more like "being locked into someone else's demand chain" than creating and expanding demand itself.
    • Contingent demand ≠ firm contracts. In May 2026 the company disclosed contingent demand commitments from 4 large customers with total potential value above $1 billion, but these commitments become firm contracts only after customers themselves receive downstream funded orders, so conversion can take time. The report repeatedly emphasizes that "high demand does not equal high-quality, billable, collectible firm contracts". This shows that its "indispensability" has not yet fully monetized into locked long-term revenue.

    In other words: short-term stickiness is strong because primes cannot easily switch, but long-term sustainability is weakened by the triple factors of concentration + budget dependence + derivative demand. This is indispensability that can be punctured at single points.

    Layer 3: social and regulatory sustainability, legal and mainstream but policy-colored

    This Baillie Gifford question also requires that the growth model "not depend on harming society or regulation". Karman's growth model is winning orders through scale, qualifications, and acquisitions. It is not built on price-war subsidies or consumer exploitation. There is no negative externality of the "extracting from users" type, which is clean. But it is naturally framed by defense budgets, export controls, ITAR, and similar regulation, and missile defense/hypersonics/tactical missiles are defense categories with ethical controversy. It is part of a legal, mainstream defense supply chain, and social acceptance depends on one's view of defense spending itself. Regulatory risk is more about budget approval and export compliance than about the business model being shut down by regulators. On Baillie Gifford's yardstick of "not relying on harming society for growth", it does not cross a red line, but it is not an uncontroversial consumer/technology growth story either.

    Baillie Gifford summary

    Baillie Gifford, which pushes upside into years 3-10, would recognize that sole-source embedding + requalification barriers mean leading primes cannot easily live without Karman in the short term, which adds points for stickiness. But "growth sustainability" needs a straightforward discount: its indispensability is highly concentrated, depends on defense budgets and prime-contractor derivative demand, and key demand signals remain contingent rather than firm. Social/regulatory sustainability is legal and mainstream, but carries defense-policy color. Overall judgment: the stickiness dimension passes and adds points; the sustainability dimension is discounted by concentration + budget dependence + regulatory color; the overall score lands at "neutral to positive / neutral". That fits the report's Watch framing: a moat is forming, but has not yet been proven wide.

    Jun 5, 2026
  • What are the unit economics of this business, including gross margin and incremental returns? Do they improve or worsen with scale? Where does the money it earns go?3/10

    Conclusion first: unit economics are KRMN's weakest dimension under the Baillie Gifford lens and are a clear negative. Gross margin is improving, reflecting mix upgrade, but the business shows a combination of "acceptable accounting profit, weak cash profit": operating and free cash flow both turned negative, growth is consuming working capital, net margin is thin, net debt/EBITDA is high, tangible net worth is negative, and interest coverage is narrow. Baillie Gifford's ideal is "unit economics improve after scale, and self-funded cash generation compounds like a snowball". KRMN currently shows the opposite: growth fed by cash burn + leverage. As scale increases, unit economics have not improved; on the cash dimension, they have worsened. Money earned, plus money borrowed, is going entirely into capex and frequent acquisitions, not shareholder returns.

    1. Gross margin is improving, but this is the only presentable bright spot in KRMN's unit economics. Gross margin rose from 37.6% in 2023 to 38.3% in 2024 and then 40.3% in 2025. The report judges this reflects improvements in product mix, pricing, and execution quality. That direction fits Baillie Gifford's preference for "unit economics improving with scale". But gross-margin improvement has not flowed down to operating profit or cash: 2025 operating margin was about 15.5%, lower than 18.4% in 2024, and net margin was only about 3.7% for two consecutive years. In other words, every upward step in gross margin is eaten downstream by acquisition amortization, interest, and working-capital use. This is not the "structurally thickening unit economics" Baillie Gifford wants to see.

    2. Incremental returns on a cash basis are negative; this is the most striking cut. Operating cash flow was still $20.33 million / $26.65 million in 2023 and 2024, but in 2025 it turned directly negative at -$22.12 million. After $20.34 million of capex, 2025 free cash flow was about -$42.46 million. 2026Q1 operating cash flow was only $0.209 million, barely above the floor. In other words, while revenue compounded at about 29.6% from 2023-2025 and grew about 51% year over year in the quarter, each additional dollar of revenue did not bring positive distributable cash; it brought negative cash. Baillie Gifford wants incremental capital to roll into higher incremental cash returns. KRMN at this stage invests incremental capital and receives negative cash returns.

    3. Unit economics have not improved with scale; the cash dimension has even worsened. The core problem is that growth is consuming working capital. The report states that the main reason for 2025 cash-flow deterioration was a $49.08 million increase in contract assets, an $18.36 million increase in receivables, and a $16.88 million decrease in accounts payable and accrued liabilities. By 2026Q1, contract assets, receivables, and inventory were still rising. This shows that KRMN's growth is capital-heavy growth that consumes working capital, not the compounding growth Baillie Gifford prefers: light-capital, automatically monetizing, and more efficient at the margin as scale rises. The larger the scale, the more cash gets trapped in contract assets and receivables. Scale effects are negative at the cash level. That is opposite to the Baillie Gifford ideal of better unit economics and self-funded growth with scale.

    4. Earned money + borrowed money goes to capex and debt-funded frequent acquisitions, with no shareholder returns. Capital use is very clear: 2025 cash acquisitions of MTI, ISP, and Five Axis produced net outflow of about $211.9 million; in 2026Q1 the company then acquired Seemann Composites and Materials Sciences for about $232.8 million, mainly financed by new borrowings. The result was total debt jumping from about $580.5 million at year-end 2025 to about $855.5 million in 2026Q1, with net debt of about $781.7 million and net debt/EBITDA of about 5.4x, still about 3.7x on the 2026 guidance basis. EBIT interest coverage was only about 1.6x, leaving a narrow financial buffer. At the same time, there were no stable dividends or regular buybacks from 2023-2025; cash was prioritized entirely toward acquisitions, capacity expansion, and debt service. Baillie Gifford does not object to "not paying dividends and reinvesting money for compounding", provided reinvestment generates high returns. But KRMN's reinvestment has not yet been proven to translate into real per-share cash earnings accretion, which the report lists as a key precondition for any rating upgrade.

    5. Tangible net worth is negative, so the downside quality of unit economics is also weak. At the end of 2025, goodwill of $352.5 million + intangible assets of $285.9 million = $638.4 million, exceeding shareholders' equity of $382.7 million, leaving negative tangible net worth. That means book value is almost entirely goodwill and intangibles bought through acquisitions, not tangible productive assets accumulated organically. This further confirms the judgment that this growth is assembled through capital operations, not self-funded organic cash generation by a standalone business.

    Baillie Gifford conclusion, clearly weak: unit economics are the most unfavorable and most penalized dimension for KRMN under the Baillie Gifford framework. Gross-margin improvement is a real positive directional signal, but it cannot carry the case alone: it has not translated into thicker operating profit, stronger cash, or better incremental returns. Baillie Gifford wants "unit economics improve after scale and compound through self-generated cash". KRMN offers "the cash dimension worsens after scale, and growth is fed by cash burn plus leverage", layered on top of thin net margin, high net debt/EBITDA, narrow interest coverage, and negative tangible net worth. Current unit economics have weak cash quality, scale has not brought better unit economics, and capital allocation does not return cash to shareholders. This is a clear negative dimension. To reverse this judgment, the inflection points listed in the report must appear: operating cash flow consistently recovering and materially exceeding net income, working-capital use no longer worsening rapidly, net debt/EBITDA falling below 2.5x, and acquisitions beginning to show clear per-share cash earnings accretion. Until those happen, KRMN's unit economics are not the kind of "compounding good business" Baillie Gifford would endorse.

    Jun 5, 2026
  • What conditions must all hold for it to rise fivefold in 10 years? Are those conditions realistic? What expectations are embedded in today's stock price?2/10

    Conclusion first, from a Baillie Gifford lens and clearly weak: a fivefold return over 10 years is not impossible, but it requires six or seven demanding conditions to all come true at the same time. Today the company is starting from a position of "229x conservative Owner Earnings, negative free cash flow, negative tangible net worth, net debt/EBITDA of about 5.4x, and a 52-week decline of about 56% from a high of $118". That is a path so narrow it leaves almost no room for error. Today's stock price around $52 already embeds expectations for "perfect execution as a defense compounder platform", with clearly no margin of safety. Baillie Gifford looks for upside and end states, but honestly, this is a "good-company embryo, bad price": the quality is not poor, but the price has pulled forward the future. This is a strongly negative dimension in the ten questions.

    Where fivefold has to get: first pin down the destination

    Starting from the current price of about $52 and market cap of about $7.0 billion, a fivefold 10-year return means the share price must reach about $260 and market cap about $35.0 billion. The report anchors current valuation at about 229x conservative Owner Earnings, with midpoint Owner Earnings of about $30.00 million corresponding to a market cap of about $6.87 billion; P/S of about 14.6x; P/B of about 16.9x; and EV/EBITDA of about 52.7x, still about 35.8x on the 2026 guidance EBITDA basis. Put differently, to get fivefold, either Owner Earnings/per-share cash earnings must grow fivefold with the multiple unchanged, or fundamentals must grow even more to allow for multiple compression. The latter is the more likely real-world direction.

    Conditions that must all hold, with no missing piece

    Baillie Gifford's "fivefold" never depends on a single variable; it is the product of "large fundamental compounding x valuation not collapsing". For Karman, that means the following conditions must stack successfully:

    1. Owner Earnings must compound sharply. The report's optimistic scenario already assumes 2026 Owner Earnings starting at $75.00 million, growing at 18% annually for the next 10 years, with a 9% discount rate and 3.5% terminal growth. Even then, intrinsic value per share reaches only $25-33, and the current price is "still at a roughly 57%-107% premium" to that optimistic range. To reach $260, the required compound growth rate is far above the optimistic case and must be paired with no multiple collapse. That is already "optimism on top of optimism".

    2. Valuation multiples must not compress materially. Today's 229x Owner Earnings and 14.6x P/S sit in a historically high zone, even after the stock has fallen about 56% from its $118 high. Compared with peers, Ducommun (DCO) trades at far lower P/S and EV/EBITDA, and even Kratos (KTOS), a defense-tech stock already receiving a growth premium from the market, trades at clearly lower multiples than Karman. From a starting point as high as 14.6x sales, a 10-year move toward peer multiples is the base expectation, not a tail risk. If multiples compress, fundamentals must grow even more to deliver a fivefold return. This is the most fragile link in the path.

    3. Cash flow must truly turn positive and remain above net income. The report's red line is clear: 2025 operating cash flow turned negative at -$22.12 million, free cash flow was about -$42.46 million, and 2026Q1 operating cash flow was only $0.209 million. The report specifically says "growth is consuming working capital"; in 2025, contract assets alone consumed $49.08 million of cash. Baillie Gifford wants compounding free cash flow, not accounting growth trapped in receivables/contract assets. This item is currently negative and must move from negative to positive, then from positive to strong.

    4. Leverage must fall meaningfully. Net debt rose from about $782 million at the end of 2025 to total debt of about $855.5 million in 2026Q1 after the Seemann/MSC acquisitions. Net debt/EBITDA was about 5.4x, still about 3.7x using the 2026 guidance midpoint EBITDA, and EBIT interest coverage was only about 1.6x. The report names "net debt/EBITDA sustainably falling below 2.5x" as a precondition for a rating upgrade. With high leverage, any program delay or budget volatility during the next 10 years could force dilutive financing and eat into per-share compounding.

    5. Acquisition integration must truly produce per-share cash earnings accretion. The company had about $211.9 million of net cash outflow for three acquisitions in 2025, then spent about $232.8 million on Seemann/MSC in 2026Q1, mainly with borrowings. The report acknowledges that "the direction has industrial logic, but it is buying quickly and buying a lot, and whether the acquisitions can truly translate into real per-share cash earnings has not yet been fully proven". The company also admitted to material internal-control weaknesses at year-end 2025. For a fivefold outcome, the platform acquisition story must move from "puzzle pieces" to verifiable cash compounding.

    6. Contingent demand must turn into firm contracts. The company says backlog exceeds $1 billion, and in May 2026 it disclosed contingent demand commitments from four large customers with total potential value above $1 billion, while the active opportunity pipeline expanded substantially versus a year earlier. But the report repeatedly stresses that "high demand ≠ high-quality, billable, collectible firm contracts". A fivefold outcome requires these potential demands to actually be signed, delivered, and collected, not remain at the commitment stage.

    7. Customer concentration must not go wrong. The top three customers accounted for 28.5% / 12.8% / 10.2% of 2025 revenue, more than half combined, and a single supplier accounted for about 23.8% of payables. Over 10 years, any large program being internalized by a prime through make-or-buy or being delayed could be enough to break the compounding curve.

    Are these conditions realistic? Honest judgment: not very realistic

    The issue appears when the seven conditions above are multiplied together rather than viewed separately. Each one individually is "possible", but Baillie Gifford's fivefold case requires them to hold simultaneously and persist for 10 years. Starting from a historical high valuation of about 229x Owner Earnings, layered with negative free cash flow, negative tangible net worth, 5.4x leverage, a new CEO who took office in March 2026, short public history, and unresolved material internal-control weaknesses, downside pressure on the multiple is structural and base-case, not a tail risk. The report's own three-scenario 10-year expected annualized returns already make the point: conservative about -12%/year, neutral about -4%/year, and optimistic only about +4%~+6%/year. Even the optimistic annualized compounding is far below the roughly +17%/year needed for a fivefold return. In other words, the report's DCF already places "fivefold" outside the optimistic assumptions, in the tail. The report's judgment on "beating a broad defense ETF" applies equally to the fivefold case: it requires "sustained high growth, successful acquisitions, falling leverage, and no valuation collapse" all at once. The path is too narrow.

    What today's stock price embeds

    The current price of about $52 is at a roughly 159%-299% premium to the report's reasonable intrinsic-value range of $13-20, and still a roughly 57%-107% premium to the optimistic range of $25-33. The report's ideal buy range is $9-14, acceptable hold range is $15-25, and above $35 is clearly overvalued, where the current price sits. This means the market has already priced Karman as a "perfectly executing defense compounder platform": high-quality backlog conversion, smooth acquisition integration, falling leverage, sustained improvement in margins and cash conversion, and the market still granting a high-growth premium 10 years from now. The best outcomes stacked together have already been prepaid. There is clearly no margin of safety, and no room for error.

    Baillie Gifford conclusion

    A fivefold return over 10 years is not impossible, but the required conditions are extremely demanding, interdependent, and start from historically high valuation plus negative cash flow/negative tangible net worth. The path is too narrow to be realistic. Today's stock price already embeds overly optimistic "perfect execution" expectations and offers no margin of safety. Baillie Gifford likes upside and can tolerate high valuations for true winners, but only when the end-state upside is far larger than what has already been priced. Karman is the opposite: the quality, including end markets, customer embedding, and qualification barriers, is a "good-company embryo", but the price has already pulled forward many years of smooth execution. Q9 is a strongly negative dimension in this growth-ten-question framework: not because the business is bad, but because the current price has already paid in advance for almost all the good fortune required to get fivefold.

    Jun 5, 2026
  • Why has the market not realized all of this yet? Is it too hard to understand, too easy to dismiss, or too far out for investors to see? What could become the "narrative inflection point"?3/10

    Conclusion first: this is an "anti-Baillie Gifford" question. The market has not failed to realize that KRMN could be great. On the contrary, the market has already fully, even excessively, priced in the long-term narrative of a "perfectly executing defense and space compounder platform": P/E of about 229x, P/S of about 14.6x, EV/EBITDA of about 52.7x, about 229x conservative Owner Earnings, and a 159%-299% premium to the reasonable value range. So there is no cognitive edge of the type Baillie Gifford values most: "too hard to understand / too easy to dismiss / too far out to see". What the market has relatively underappreciated and under-debated is instead the negative side of the narrative: operating cash flow turning negative, leverage rising, negative tangible net worth, and material internal-control weaknesses, all overshadowed by the optimistic growth story. But balance is needed: the stock has already fallen about 56% from a high of about $118, and recently old shareholders reduced holdings through an offering at about $61, so the market is not one-way euphoric and has begun digesting some risk.

    1. The market understands and looks far ahead; the problem is that it looks too far ahead and too smoothly

    The report lays out both the bull and bear sides clearly, while market pricing has clearly rewarded only the bull side:

    • Bull side, already well recognized and priced by the market: attractive end markets, including missile defense, hypersonics, tactical missiles, space launch, and new maritime defense; deep customer embedding, with 130+ programs, 80+ customers, and some sole/single-source qualifications; rapid growth, with a 2023-2025 revenue CAGR of about 29.6%, about 51% year-over-year growth in 2026Q1, backlog above $1 billion, and May disclosure of contingent demand commitments from four large customers with potential value above $1 billion.

    • Bear side, relatively ignored or insufficiently discounted by the market: 2025 operating cash flow turned negative, free cash flow was about -$42.46 million; net debt/EBITDA was about 5.4x; at year-end 2025, goodwill + intangible assets were about $638.4 million while shareholders' equity was only $382.7 million, leaving negative tangible net worth; the 10-K acknowledged material internal-control weaknesses as of the end of 2025, including COSO, ITGC, and process-level controls.

    In other words, Baillie Gifford's usual cognitive gap, where "the market does not understand how great this company can become", is reversed for KRMN. A 229x P/E means the market not only understands the platform story, but has also prepaid for many years of smooth execution. The report captures it in one sentence: "Karman currently looks more like a stock priced by the market as a 'perfectly executing defense compounder platform', while in reality it remains an industrial company with high customer concentration, acquisition dependence, unproven cash flow, and rising leverage".

    2. What is truly "not fully priced" is downside, not upside

    If one must apply the frame of "what has the market not realized", the answer is not "it will be great", but "growth can continue while shareholder returns are poor". The report defines this as the cash-burning roll-up risk where "the story works, the investment does not": more revenue may produce only more working-capital use, with contract assets alone consuming $49.08 million of cash in 2025, higher debt, with total debt rising from $580.5 million at year-end 2025 to $855.5 million in 2026Q1, and thinner real free cash flow. This logic chain of "accounting profit is not poor, cash profit is not solid" is relatively underweighted in the current 229x valuation. The market has treated "high growth" directly as "high-quality distributable cash-flow growth", while working capital and leverage sit between those two ideas.

    3. But the market is not one-way euphoric; risk has begun to be priced

    Honestly, KRMN should not be described as a pure irrational bubble:

    • The stock has fallen from a 52-week high of about $118 to about $52, a drawdown of about 56%, showing that the extreme end of the optimistic narrative has already been revised by the market itself.
    • At the end of May 2026, old shareholders sold about 14.00 million shares through an offering at about $61, with the company receiving no proceeds. This is a signal of early/PE shareholders reducing exposure at a high level, and the market's absorption of that is itself part of the valuation reassessment.
    • Sell-side views remain split: some banks have recently maintained Buy ratings, while the report's cross-check of three valuation methods gives intrinsic value of only $7-33, more than a full turn below the current price. This is not "the whole market cannot see it", but "growth investors and value investors applying very different discount rates to the same facts".

    4. Narrative inflection points exist in both directions, and both hang on cash flow

    • Upside inflection, validating the platform story: operating cash flow turns positive for consecutive periods and materially exceeds net income → net debt/EBITDA sustainably falls below 2.5x → material internal-control weaknesses are remediated → Seemann/MSC and other acquisitions begin to show clear per-share cash earnings accretion → contingent demand steadily converts into firm orders without broad delays. If these five things happen together, the "perfect execution platform" narrative is proven true rather than false, and the high valuation gains fundamental support. The report also explicitly says these are conditions under which it would consider upgrading the rating.

    • Downside inflection, narrative switch: revenue keeps growing quickly, but operating cash flow remains weak, contract assets/receivables continue expanding too fast, leverage does not fall, internal controls are not fixed, and the company undertakes another large debt-funded acquisition. At that point, the market's perception of the "growth premium" would shift from "defense compounder platform" to "cash-burning roll-up buying growth with debt", and valuation multiples would revert toward traditional industrial-company levels. The report estimates that in an extreme case, especially given negative tangible net worth and lack of asset downside support, this could produce 60%-80% permanent capital loss.

    Honest Baillie Gifford conclusion: for KRMN, the cognitive gap is negative/neutral. There is no upside edge from "too hard to understand, too easy to dismiss, or too far out to see". The market already understands the platform narrative and looks far ahead; the current 229x P/E prices in optimistic assumptions. What is underpriced is more likely the downside risk from cash flow, leverage, and internal controls. The only buffer is that the stock has already drawn down about 56% from its high, and old shareholders have reduced exposure at a high level, showing that risk is partly being priced and the market is not one-way euphoric. For an LTGG growth investor, what is missing is not "greatness the market has not yet discovered", but "price room for mistakes". That is why the rating is Watch: what one should wait for is either the upside inflection above being confirmed by cash flow, or the stock price returning to a level that reflects downside risk, not a bet on a nonexistent cognitive edge.

    Jun 5, 2026
Ask about this report

Members can ask about this report; once answered it appears under "Reader Q&A" on this page. You can also highlight a passage in the text to ask about it directly.